Septy Pharmaceuticals Private Limited

Septy Pharmaceuticals Private Limited - pharma in Assam, India. FY 2026 financials & compliance.
CIN U24232AS2006PTC008149 Incorporated 12 May 2006 ROC Guwahati HQ Assam, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹1.66 Cr
▲ 566% YoY
Net loss · FY 2024
₹5.61 Lakh
Net margin -3.4%
EBITDA · FY 2024
₹2.06 Cr
EBITDA margin 124.5%
Authorised capital
₹3.5 Cr
Registered with MCA
Paid-up capital
₹2.17 Cr
Issued & subscribed
Open charges
₹29.99 Cr
Satisfied ₹11.03 Cr
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings

About Septy Pharmaceuticals Private Limited

Data last updated:

Septy Pharmaceuticals Private Limited is a private limited company based in Assam, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 May 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24232AS2006PTC008149. Its GSTIN is 18AALCS0698C2Z3 (Assam). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹2.17 Cr. It is led by directors Anju Kumari and Suresh Chand Saini.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Kekanikuchi Septy Dipteswari Road P.O. Moranjana P.S. Rangiya, Assam, India.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.66 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5.61 Lakh (net margin -3.4%) and EBITDA of ₹2.06 Cr (EBITDA margin 124.5%). Revenue has grown at a compounded annual rate (CAGR) of 907% over five years.

As per MCA filings, the company has open charges of ₹29.99 Cr and satisfied charges of ₹11.03 Cr on record. Court records list 1 case involving the company, including 1 filed against it.

Septy Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-16-0005670). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232AS2006PTC008149
Registration Number 008149
Incorporation Date 12 May 2006
ROC Guwahati
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-AS-16-0005670

Recognitions & Rankings of Septy Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-AS-16-0005670

Contact details

Septy Pharmaceuticals Private Limited's registered office is in Assam. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Kekanikuchi Septy Dipteswari Road P.O. Moranjana P.S. Rangiya, Assam, India
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Septy Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Septy Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Septy Pharmaceuticals is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities

To see the full business activity and turnover split of Septy Pharmaceuticals Private Limited, buy the company report.

Financials of Septy Pharmaceuticals Private Limited

FY 2024 filings available

Septy Pharmaceuticals Private Limited reported revenue of ₹1.66 Cr (up 566% YoY) for FY 2024.

Revenue · FY 2024
₹1.66 Cr ▲ 566%
Net loss · FY 2024
₹5.61 Lakh margin -3.4%
EBITDA · FY 2024
₹2.06 Cr margin 124.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 566%
5 years · compounded
▲ 907%
EBITDA CAGR growth
1 year
▲ 216%
3 years · compounded
▲ 911%
5 years · compounded
▲ 70%

Revenue has grown at a compounded annual rate (CAGR) of 907% over five years, including 566% growth in the latest year. EBITDA rose 216% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.06 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.61 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin124.5%
Net Profit Margin-3.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Septy Pharmaceuticals Private Limited, buy the company report.

Board of directors of Septy Pharmaceuticals Private Limited

Septy Pharmaceuticals has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anju KumariDirector15 Mar 20224 Years 8 MonthsCurrent
Suresh Chand SainiDirector07 Mar 20224 Years 8 MonthsCurrent

Auditor

Septy Pharmaceuticals Private Limited is audited by Hari Singh & Associates. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
Hari Singh & Associates.FY 2022323509E

Shareholding

The shareholding of Septy Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Septy Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹29.99 Cr
Satisfied charges
₹11.03 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹29.99 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Jul 2022100684083Hdfc Bank Limited₹29.99 CrOpen
10 Jun 201110294437Assam Gramin Vikash Bank₹6.08 CrSatisfied
03 Mar 200910146163Allahabad Bank₹4.95 CrSatisfied

To see the full charge records of Septy Pharmaceuticals Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Septy Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Septy Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
18AALCS0698C2Z3AssamActive01 Jul 2017

To see the full GST registrations and return filing status of Septy Pharmaceuticals Private Limited, buy the company report.

Recent activity

Septy Pharmaceuticals Private Limited has 11 board changes on record since 2013: 2 appointments and 9 cessations. The latest: Amar Jyoti Das ceased to be Director on 23 Mar 2022.

AGM
Septy Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 29.99 Cr registered on 04 Jul 2022 with Charge ID 100684083 was modified on 24 Jun 2024.
Filing
Septy Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 29.99 Cr with Charge ID 100684083 was registered on 04 Jul 2022.
Charges
A charge registered on 10 Jun 2011 via Charge ID 10294437 with Assam Gramin Vikash Bank was fully satisfied on 16 Jun 2022.
Ceased
Amar Jyoti Das ceased to be Director.
Appointed
Anju Kumari was appointed as Director.
Ceased
Atanu Barua ceased to be Director.
Ceased
Bipul Medhi ceased to be Director.
Ceased
Keshab Mahanta ceased to be Director.
Ceased
Ronit Phukan ceased to be Director.
Appointed
Suresh Chand Saini was appointed as Director.

9 earlier events are in the company report.

Frequently asked questions

Septy Pharmaceuticals is an active private limited company based in Assam, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 May 2006 (20+ years old) and is registered under CIN U24232AS2006PTC008149.

Septy Pharmaceuticals has 2 current directors:

The latest financial statements of Septy Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Septy Pharmaceuticals is 18AALCS0698C2Z3, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Septy Pharmaceuticals is U24232AS2006PTC008149. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Septy Pharmaceuticals has 1 court case on record: 1 filed against it.

Septy Pharmaceuticals was incorporated on 12 May 2006, making it 20+ years old. It is registered with the Registrar of Companies, Guwahati.

Amar Jyoti Das ceased to be Director on 23 Mar 2022. Anju Kumari was appointed as Director on 15 Mar 2022. Atanu Barua ceased to be Director on 14 Mar 2022. Septy Pharmaceuticals has 11 board changes on record in total.

Yes, Septy Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-AS-16-0005670).

The registered office of Septy Pharmaceuticals is at Kekanikuchi Septy Dipteswari Road P.O. Moranjana P.S. Rangiya, Assam, India.